Abstract:The non-heme iron/α-ketoglutarate dependent enzymes
SnoK
and SnoN from Streptomyces nogalater are involved
in the biosynthesis of anthracycline nogalamycin. Although they have
similar active sites, SnoK is responsible for carbocyclization whereas
SnoN solely catalyzes the hydroxyl epimerization. Herein, we performed
docking, molecular simulations, and a series of combined quantum mechanics
and molecular mechanics (QM/MM) calculations to illuminate the mechanisms
of two enzymes. The catalytic reactions of two e… Show more
“…The Fe(IV) = O species in the active site of the nonheme 2OG-dependent enzymes can exist either as a trigonal bipyramidal coordinate (5C) ,− configuration or octahedral-coordinate (6C) configuration. − The QM/MM study of AsqJ and EFE showed that 6C Fe(IV) = O resembles closely to the experimentally trapped Fe(IV) = O species obtained in prolyl-4-hydroxylase and taurine dioxygenase (TauD) enzymes. , However, it is not known whether the 5C or 6C is the preferred configuration in T6ODM.…”
Section: Resultssupporting
confidence: 94%
“…To understand the oxygen activation by Fe(II), QM/MM calculations were performed on S = 0, S = 1, S = 2, and S = 3 spin state surfaces for the three representative structures obtained from the MD simulations of Fe(III) super-oxo complex. The quintet state was suggested to be most favorable in the context of 2OG-dependent nonheme iron enzymes from previous experimental electron paramagnetic resonance (EPR) Mössbauer spectroscopy studies and the QM/MM studies; ,,,− , therefore, it was chosen as the reference to compute the relative energies of other spin states for T6ODM.…”
Two homologous 2-oxoglutarate-dependent (ODD) nonheme enzymes thebaine 6-O-demethylase (T6ODM) and codeine-3-O-demethylase (CODM), are involved in the morphine biosynthesis pathway from thebaine, catalyzing the O-demethylation reaction with precise regioselectivity at C6 and C3 positions of thebaine respectively. We investigated the origin of the regioselectivity of these enzymes by combined molecular dynamics (MD) and quantum mechanics/molecular mechanics (QM/MM) calculations and found that Thebaine binds at the two distinct sites of T6ODM and CODM, which determines the regioselectivity of the enzymes. A remarkable oxo rotation is observed in the decarboxylation process. Starting from the closed pentacoordinate configuration, the C-terminal lid adopts an open conformation in the octahedral Fe(IV) = O complex to facilitate the subsequent demethylation. Phe241 and Phe311 stabilize the substrate in the binding pocket, while Arg219 acts as a gatekeeper residue to stabilize the substrate. Our results unravel the regioselectivity in 2-OG dependent nonheme enzymes and may shed light for exploring the substrate scope of these enzymes and developing novel biotechnology for morphine biosynthesis.
“…The Fe(IV) = O species in the active site of the nonheme 2OG-dependent enzymes can exist either as a trigonal bipyramidal coordinate (5C) ,− configuration or octahedral-coordinate (6C) configuration. − The QM/MM study of AsqJ and EFE showed that 6C Fe(IV) = O resembles closely to the experimentally trapped Fe(IV) = O species obtained in prolyl-4-hydroxylase and taurine dioxygenase (TauD) enzymes. , However, it is not known whether the 5C or 6C is the preferred configuration in T6ODM.…”
Section: Resultssupporting
confidence: 94%
“…To understand the oxygen activation by Fe(II), QM/MM calculations were performed on S = 0, S = 1, S = 2, and S = 3 spin state surfaces for the three representative structures obtained from the MD simulations of Fe(III) super-oxo complex. The quintet state was suggested to be most favorable in the context of 2OG-dependent nonheme iron enzymes from previous experimental electron paramagnetic resonance (EPR) Mössbauer spectroscopy studies and the QM/MM studies; ,,,− , therefore, it was chosen as the reference to compute the relative energies of other spin states for T6ODM.…”
Two homologous 2-oxoglutarate-dependent (ODD) nonheme enzymes thebaine 6-O-demethylase (T6ODM) and codeine-3-O-demethylase (CODM), are involved in the morphine biosynthesis pathway from thebaine, catalyzing the O-demethylation reaction with precise regioselectivity at C6 and C3 positions of thebaine respectively. We investigated the origin of the regioselectivity of these enzymes by combined molecular dynamics (MD) and quantum mechanics/molecular mechanics (QM/MM) calculations and found that Thebaine binds at the two distinct sites of T6ODM and CODM, which determines the regioselectivity of the enzymes. A remarkable oxo rotation is observed in the decarboxylation process. Starting from the closed pentacoordinate configuration, the C-terminal lid adopts an open conformation in the octahedral Fe(IV) = O complex to facilitate the subsequent demethylation. Phe241 and Phe311 stabilize the substrate in the binding pocket, while Arg219 acts as a gatekeeper residue to stabilize the substrate. Our results unravel the regioselectivity in 2-OG dependent nonheme enzymes and may shed light for exploring the substrate scope of these enzymes and developing novel biotechnology for morphine biosynthesis.
“…Fe IV is coordinated in a distorted octahedral geometry with the succinate bound in a bidentate fashion. Such an arrangement of the active site was proposed in other studies of non‐haem iron dioxygenases, [56–59] however, depending on the surroundings of the active site, Fe IV can also be in a trigonal bipyramidal arrangement [55, 60–62] or a water molecule can bind to Fe IV as an equatorial ligand [63, 64] . As expected for this complex, the electronic configuration of S is π* xy 1 π* xz 1 π* yz 1 σ* 1 (the occupied orbitals are shown in Figure S2 in the Supporting Information), the σ* orbital is virtual and oriented along the O−Fe−N(His‐279) axis and thus able to accept an electron from the substrate during the initial HAT.…”
Section: Resultssupporting
confidence: 60%
“…Such an arrangement of the active site was proposed in other studies of non-haem iron dioxygenases, [56][57][58][59] however,d epending on the surroundings of the actives ite, Fe IV can also be in a trigonal bipyramidal arrangement [55,[60][61][62] or aw ater molecule can bind to Fe IV as an equatorial ligand. [63,64] As expected for this complex, the electronic configurationo fS is p* xy…”
Section: Initial Hatf or The Native Substratessupporting
Clavaminic acid synthase from Streptomyces clavuligerus is an FeII/2‐oxoglutarate‐dependent dioxygenase, crucial for the biosynthesis of the β‐lactamase inhibitor clavulanic acid. It catalyses three consecutive oxidative reactions, that is, hydroxylation, cyclisation and desaturation, in a single binding cavity. As follows from the results of this QM/MM study, CAS versatility and selectivity depends on the binding cavity, which interplays differently with the substrate for each reaction. The enzyme–substrate interactions affect the substrate's ability to re‐position during the reaction, either constraining it in its primary position, which impedes processes other than oxygen rebound, or allowing change, which facilitates desaturation. This differential effect originates from two aspartate residues, which strongly interact with the guanidine group of the hydroxylation substrate and stabilise the orientation of the molecule. These residues interact less effectively with the smaller amine group of the desaturation substrate(s), aiding their re‐positioning and the subsequent formation of a double bond.
“…The QM/MM method has been applied in the studies of mononuclear iron-containing enzymes. − In our calculations, the whole system was divided into QM and MM regions. All QM/MM calculations were conducted by employing the ChemShell package, which combines TURBOMOLE and DL_POLY programs for treating the QM and MM regions, respectively.…”
PtmU3 is a newly identified nonheme diiron monooxygenase, which installs a C-5 β-hydroxyl group into the C-19 CoA-ester intermediate involved in the biosynthesis of unique diterpene-derived scaffolds of platensimycin and platencin. PtmU3 possesses a noncanonical diiron active site architecture of a saturated six-coordinate iron center and lacks the μ-oxo bridge. Although the hydroxylation process is a simple reaction for nonheme mononuclear iron-dependent enzymes, how PtmU3 employs the diiron center to catalyze the H-abstraction and OH-rebound is still unknown. In particular, the electronic characteristic of diiron is also unclear. To understand the catalytic mechanism of PtmU3, we constructed two reactant models in which both the Fe1 II −Fe2 III −superoxo and Fe1 II − Fe2 IV O are considered to trigger the H-abstraction and performed a series of quantum mechanics/molecular mechanics calculations. Our calculation results reveal that PtmU3 is a special monooxygenase, that is, both atoms of the dioxygen molecule can be incorporated into two molecules of the substrate by the successive reactions. In the first-round reaction, PtmU3 uses the Fe1 II − Fe2 III −superoxo to install a hydroxyl group into the substrate, generating the high-reactive Fe1 II −Fe2 IV O complex. In the secondround reaction, the Fe1 II −Fe2 IV O species is responsible for the hydroxylation of another molecule of the substrate. In the diiron center, Fe2 adopts the high spin state (S = 5/2) during the catalysis, whereas for Fe1, in addition to its structural role, it may also play an assistant role for Fe1 catalysis. In the two successive OH-installing steps, the H-abstraction is always the rate-liming step. E241 and D308 not only act as bridging ligands to connect two Fe ions but also take part in the electron reorganization. Owing to the high reactivity of Fe1 II −Fe2 IV O compared to Fe1 II −Fe2 III −superoxo, besides the C5-hydroxylation, the C3-or C18hydroxylation was also calculated to be feasible.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.